432 related articles for article (PubMed ID: 25886952)
21. Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007-2010).
Hayes G; Benedicenti L; Mathews K
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):35-40. PubMed ID: 26587795
[TBL] [Abstract][Full Text] [Related]
22. Is the literature inconclusive about the harm of HES? We are not sure.
Schetz M; Shaw AD; Vincent JL
Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
[No Abstract] [Full Text] [Related]
23. A change of colloid from hydroxyethyl starch to gelatin does not reduce rate of renal failure or mortality in surgical critical care patients: Results of a retrospective cohort study.
Albrecht FW; Glas M; Rensing H; Kindgen-Milles D; Volk T; Mathes AM
J Crit Care; 2016 Dec; 36():160-165. PubMed ID: 27546766
[TBL] [Abstract][Full Text] [Related]
24. New insights into fluid resuscitation.
Myburgh J; McIntyre L
Intensive Care Med; 2013 Jun; 39(6):998-1001. PubMed ID: 23559078
[TBL] [Abstract][Full Text] [Related]
25. Hydroxyethyl starch in sepsis.
Haase NR
Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
[TBL] [Abstract][Full Text] [Related]
26. Hydroxyethyl Starch for Fluid Management in Patients Undergoing Major Abdominal Surgery: A Systematic Review With Meta-analysis and Trial Sequential Analysis.
Pensier J; Deffontis L; Rollé A; Aarab Y; Capdevila M; Monet C; Carr J; Futier E; Molinari N; Jaber S; De Jong A
Anesth Analg; 2022 Apr; 134(4):686-695. PubMed ID: 34854822
[TBL] [Abstract][Full Text] [Related]
27. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies.
Bansal M; Farrugia A; Balboni S; Martin G
Curr Drug Saf; 2013 Sep; 8(4):236-45. PubMed ID: 23909705
[TBL] [Abstract][Full Text] [Related]
28. Crystalloids vs. colloids: KO at the twelfth round?
Phillips DP; Kaynar AM; Kellum JA; Gomez H
Crit Care; 2013 May; 17(3):319. PubMed ID: 23731998
[TBL] [Abstract][Full Text] [Related]
29. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis.
Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
Anesth Analg; 2012 Jan; 114(1):159-69. PubMed ID: 22184610
[TBL] [Abstract][Full Text] [Related]
30. Effect of Hydroxyethyl Starch Solution on Incidence of Acute Kidney Injury in Patients Suffering from Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.
Kieninger M; Unbekannt D; Schneiker A; Sinner B; Bele S; Prasser C
Neurocrit Care; 2017 Feb; 26(1):34-40. PubMed ID: 27059048
[TBL] [Abstract][Full Text] [Related]
31. Resuscitation Fluids in Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials.
Li B; Zhao H; Zhang J; Yan Q; Li T; Liu L
Shock; 2020 Jun; 53(6):679-685. PubMed ID: 31693630
[TBL] [Abstract][Full Text] [Related]
32. Colloids in Cardiac Surgery-Friend or Foe?
Ryhammer PK; Tang M; Hoffmann-Petersen J; Leonaviciute D; Greisen J; Storebjerg Gissel M; Jakobsen CJ
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1639-1648. PubMed ID: 28372955
[TBL] [Abstract][Full Text] [Related]
33. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
[TBL] [Abstract][Full Text] [Related]
34. Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate.
Müller RB; Ostrowski SR; Haase N; Wetterslev J; Perner A; Johansson PI
J Crit Care; 2016 Apr; 32():16-20. PubMed ID: 26810483
[TBL] [Abstract][Full Text] [Related]
35. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.
Lagny MG; Roediger L; Koch JN; Dubois F; Senard M; Donneau AF; Hubert MB; Hans GA
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):869-75. PubMed ID: 26774199
[TBL] [Abstract][Full Text] [Related]
36. Balanced 10% hydroxyethyl starch compared with balanced 6% hydroxyethyl starch and balanced crystalloid using a goal-directed hemodynamic algorithm in pancreatic surgery: A randomized clinical trial.
Werner J; Hunsicker O; Schneider A; Stein H; von Heymann C; Freitag A; Feldheiser A; Wernecke KD; Spies C
Medicine (Baltimore); 2018 Apr; 97(17):e0579. PubMed ID: 29703051
[TBL] [Abstract][Full Text] [Related]
37. Fluid replacement with hydroxyethyl starch in critical care--a reassessment.
Hartog CS; Welte T; Schlattmann P; Reinhart K
Dtsch Arztebl Int; 2013 Jun; 110(26):443-50. PubMed ID: 23885279
[TBL] [Abstract][Full Text] [Related]
38. Impact of 6% balanced hydroxyethyl starch following cardiopulmonary bypass on renal function: a retrospective study.
Lim JY; Kim YS; Kim JB
J Cardiothorac Surg; 2020 Sep; 15(1):237. PubMed ID: 32894168
[TBL] [Abstract][Full Text] [Related]
39. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.
Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
Intensive Care Med; 2013 Apr; 39(4):558-68. PubMed ID: 23407978
[TBL] [Abstract][Full Text] [Related]
40. Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression.
Ma PL; Peng XX; Du B; Hu XL; Gong YC; Wang Y; Xi XM
Chin Med J (Engl); 2015 Sep; 128(17):2374-82. PubMed ID: 26315087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
